Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
December 18, 2019
AAM
Women-Powered Health Policy: 500 and Counting
Blog
November 19, 2019
AAM
Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA
Blog
November 18, 2019
AAM
Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner
Blog
November 14, 2019
AAM
How Our Associate Members Make the World Healthier
Blog
November 11, 2019
AAM
GRx+Biosims 2019 Year 2: The Recap
Blog
October 29, 2019
AAM
AAM Testimony on the Generic Global Supply Chain—Five Takeaways
Blog
October 29, 2019
AAM
GRx+Biosims: Back + Better Than Ever
Blog
October 7, 2019
AAM
A Positive Impact: How Our Members Show They Care
Blog
October 3, 2019
AAM
GRx+Biosims Spotlight: The Exposition
Blog
September 23, 2019
AAM
Happy Birthday, Generic Prescription Drugs: 35 Years of Competition
Blog
August 26, 2019
AAM
Giving, Volunteering and More: How Our Members Show They Care
Blog
August 24, 2019
AAM
2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
